Status:
UNKNOWN
Premedication Dyclonine Improves Visibility During Bowel Cleansing for Colonoscopy
Lead Sponsor:
Changhai Hospital
Conditions:
Bowel Preparation Scale
the Amount of Air Bubble
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
In this randomized controlled study, consecutive outpatients scheduled for elective colonoscopy were randomized into two groups. Group A patients (n = 300) used only 3L PEG before colonoscopy. Patient...
Eligibility Criteria
Inclusion
- Patients are between 18-75 years old
- undergoing colonoscopy for diagnostic investigation, colorectal cancer screening or follow-up
Exclusion
- suspected gastrointestinal obstruction or perforation
- severe acute inflammatory bowel disease
- toxic megacolon
- ileus or gastric retention, ileostomy,
- hypersensitivity to any of the ingredients
- pregnancy and lactation and/or at a risk of becoming pregnant
Key Trial Info
Start Date :
December 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2018
Estimated Enrollment :
580 Patients enrolled
Trial Details
Trial ID
NCT03352700
Start Date
December 1 2017
End Date
February 1 2018
Last Update
November 24 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Changhai Hospital, Second Military Medical University
Shanghai, China, 200433